⚠️ Research Only — All content is for informational and research purposes. Not medical advice. Read full disclaimer

Rapamycin Peptide

Also known as: mTOR Modulator, Sirolimus, Rapamune

Rapamycin peptide is a potent mTOR pathway inhibitor originally developed as an immunosuppressant that has gained attention for its potential anti-aging and longevity benefits.

Last updated: February 18, 2026Reviewed by: Peptide Research Team

Rapamycin Peptide is a 914.18 g/mol research peptide. Rapamycin peptide is a potent mTOR pathway inhibitor originally developed as an immunosuppressant that has gained attention for its potential anti-aging and longevity benefits.

Also called: mTOR Modulator, Sirolimus, Rapamune

914.18 g/mol

Molecular Weight

Daltons

2

Strong Evidence

benefits

5

Studies Cited

peer-reviewed

1-6

Typical Dose

mg

Overview

Rapamycin peptide targets the mechanistic target of rapamycin (mTOR) pathway, a central regulator of cell growth, metabolism, and aging processes. Originally discovered from the bacterium Streptomyces hygroscopicus on Easter Island, rapamycin blocks mTORC1 signaling by binding to FKBP12 and forming a complex that inhibits mTOR kinase activity. This inhibition triggers autophagy, reduces protein synthesis, and shifts cellular metabolism toward maintenance rather than growth. Research demonstrates rapamycin's ability to extend lifespan in multiple species, improve healthspan markers, and potentially delay age-related diseases. The compound's unique mechanism makes it one of the most studied anti-aging interventions, though its immunosuppressive properties require careful dosing protocols for longevity applications.

Key Takeaways: Rapamycin Peptide

  • Strongest evidence supports Rapamycin Peptide for lifespan extension and enhanced autophagy
  • Research doses typically range from 1 to 6 mg via oral
  • 2 benefits with strong evidence, 4 moderate, 1 preliminary
  • Half-life: 62 hours
  • 5 cited research studies in this guide

Mechanism of Action

Rapamycin binds to the intracellular protein FKBP12, forming a complex that specifically inhibits mTORC1 (mechanistic target of rapamycin complex 1). This inhibition blocks the phosphorylation of downstream targets including S6K1 and 4E-BP1, reducing protein synthesis and cell growth while promoting autophagy. The resulting metabolic shift enhances cellular maintenance processes, reduces oxidative stress, and may slow aging by optimizing the balance between anabolic and catabolic pathways.

Research Benefits

Rapamycin Peptide at a Glance

Primary mechanism:

Rapamycin binds to the intracellular protein FKBP12, forming a complex that specifically inhibits mTORC1 (mechanistic target of rapamycin complex 1).

Top researched benefits:
Lifespan ExtensionEnhanced AutophagyImproved Metabolic HealthCardiovascular ProtectionNeuroprotectionCancer PreventionImmune System Modulation

Lifespan Extension

Strong Evidence

Rapamycin consistently extends lifespan in multiple species including mice, flies, and worms by 10-25%. The compound delays age-related pathology and extends both median and maximum lifespan, making it one of the most robust longevity interventions identified.

Enhanced Autophagy

Strong Evidence

mTORC1 inhibition directly activates autophagy pathways, promoting cellular cleanup of damaged organelles and misfolded proteins. This enhanced autophagy may protect against neurodegenerative diseases and improve cellular function during aging.

Improved Metabolic Health

Moderate Evidence

Rapamycin treatment improves glucose tolerance, enhances insulin sensitivity, and promotes metabolic flexibility. These effects may protect against type 2 diabetes and metabolic syndrome, though results can vary based on dosing protocols.

Cardiovascular Protection

Moderate Evidence

mTOR inhibition reduces vascular inflammation, improves endothelial function, and may slow arterial aging. Studies show rapamycin can reduce atherosclerosis progression and improve cardiac function in aging models.

Neuroprotection

Moderate Evidence

Rapamycin crosses the blood-brain barrier and may protect against neurodegenerative diseases through enhanced neuronal autophagy and reduced tau pathology. Research suggests potential benefits for Alzheimer's disease and cognitive aging.

Cancer Prevention

Moderate Evidence

mTOR pathway inhibition reduces cancer risk by suppressing tumor growth signals and promoting apoptosis in abnormal cells. Rapamycin shows promise as a cancer prevention strategy, particularly for age-related malignancies.

Immune System Modulation

Preliminary

Low-dose rapamycin may enhance immune function in older adults by promoting T-cell memory formation while reducing chronic inflammation. This differs from high-dose immunosuppressive effects seen in transplant medicine.

Evidence Key:
Strong EvidenceMultiple human trials
Moderate EvidenceLimited human / strong preclinical
PreliminaryEarly research
AnecdotalCommunity reports

Research Dosing Protocols

Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

Research ProtocolDose RangeRoute
Longevity/Anti-aging16 mgoral
Metabolic Research210 mgoral

Frequency

Once weekly to 3x weekly

Timing

With or without food, maintain consistent timing

Cycle Length

Intermittent protocols preferred - 3 months on, 1 month off

Research Notes

  • 1Start with lowest effective dose to assess tolerance
  • 2Weekly dosing may provide benefits while minimizing side effects
  • 3Monitor blood glucose and lipid levels regularly
  • 4Avoid continuous daily dosing for longevity applications
  • 5Consider drug holidays to prevent tolerance

Reconstitution Guide

Standard Reconstitution

Vial Size

0 mg

Bacteriostatic Water

0 mL

Concentration

NaN mcg

per 0.1 mL (10 units)

Step-by-Step Guide

1

Gather Materials

Rapamycin Peptide vial, bacteriostatic water, alcohol swabs, insulin syringes.

2

Equilibrate Temperature

Remove the vial from storage and allow it to reach room temperature (5-10 minutes).

3

Sanitize

Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.

4

Draw Water

Draw 0 mL of bacteriostatic water into a syringe.

5

Add Water to Vial

Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.

6

Mix Gently

Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.

7

Store Properly

Refrigerate at Room temperature. 2-3 years.

Storage Temperature

Room temperature

Shelf Life

2-3 years

Important Notes

  • Rapamycin is typically available as oral tablets or capsules
  • Store in original packaging away from light and moisture
  • Lipid-based formulations may improve absorption
  • Injectable forms require specialized pharmaceutical preparation

Safety & Side Effects

Reported Side Effects

  • !Mouth ulcers and oral lesions
  • !Increased infection risk due to immunosuppression
  • !Elevated blood glucose and insulin resistance
  • !Hyperlipidemia and increased triglycerides
  • !Delayed wound healing
  • !Fatigue and weakness
  • !Gastrointestinal upset including diarrhea
  • !Thrombocytopenia (low platelet count)
  • !Proteinuria (protein in urine)
  • !Potential male fertility effects

Potential Interactions

  • CYP3A4 inhibitors (ketoconazole, grapefruit juice) increase rapamycin levels significantly
  • CYP3A4 inducers (rifampin, St. John's Wort) decrease rapamycin effectiveness
  • Live vaccines should be avoided due to immunosuppressive effects
  • ACE inhibitors may increase risk of angioedema when combined with mTOR inhibitors
  • Strong interaction with cyclosporine requiring dose adjustments

Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.

Research Studies

The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.

Rapamycin extends life span of middle-aged mice

Harrison DE, et al.2009Nature
PMID: 19587680

Landmark study showing rapamycin extended lifespan by 14% in female mice and 9% in male mice when treatment began at 20 months of age, equivalent to 60 human years.

mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome

Johnson SC, et al.2013Science

Demonstrated rapamycin's ability to improve mitochondrial function and extend survival in a mouse model of mitochondrial disease through enhanced autophagy.

Rapamycin improves Alzheimer's disease-like cognitive and pathological deficits

Spilman P, et al.2010PLoS One

Showed rapamycin reduced amyloid pathology and improved cognitive function in Alzheimer's disease mouse models through enhanced autophagy clearance.

Low-dose rapamycin extends lifespan and delays age-related pathology in middle-aged mice

Fok WC, et al.2014Aging Cell

Found that even low-dose rapamycin treatment significantly extended lifespan and reduced age-related pathology without major adverse effects.

Rapamycin-induced insulin resistance is mediated by mTORC2 loss

Lamming DW, et al.2012Cell Metabolism

Identified that rapamycin's metabolic side effects result from chronic mTORC2 inhibition, suggesting intermittent dosing may avoid these issues.

Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.

Frequently Asked Questions

Research suggests 1-6mg weekly may provide anti-aging benefits while minimizing side effects. Most longevity-focused protocols use 5-6mg once weekly, though individual response varies significantly.

Cellular autophagy increases within days, but measurable health benefits typically appear after 2-3 months of consistent use. Longevity benefits accumulate over years of treatment.

Daily dosing increases side effect risk and may cause metabolic dysfunction. Weekly or intermittent protocols are preferred for longevity applications to maintain benefits while reducing adverse effects.

Yes, regular monitoring of glucose, lipids, kidney function, and blood counts is recommended. Most protocols suggest testing every 3-6 months during treatment.

Long-term safety data in healthy individuals is limited. While animal studies are promising, human longevity studies are ongoing. Careful medical supervision is essential.

Grapefruit and grapefruit juice significantly increase rapamycin blood levels and should be avoided. High-fat meals may enhance absorption but timing should remain consistent.

Rapamycin may slow aging processes and improve healthspan, but it doesn't reverse existing age-related damage. Benefits include enhanced cellular maintenance and delayed age-related pathology.

Rapamycin has the strongest lifespan extension data across species, but also carries more side effect risk than compounds like metformin or resveratrol. It's considered more potent but requiring careful management.

⚠️

Research & Educational Use Only

All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.

The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.